Short (GT)n repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress

Cell Stress and Chaperones

Volumn 17, Issue 3, 2012, Pages 329-338

  Chen, Mu ^a   Zhou, Li ^a   Ding, Hu ^a   Huang, Suli ^a   He, Meian ^a   Zhang, Xiaomin ^a   Cheng, Longxian ^b   Wang, Daowen ^a   Hu, Frank B ^a   Wu, Tangchun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary heart disease; Gene polymorphism; Heme oxygenase 1; Malonaldehyde; Oxidative stress

Indexed keywords

HEME OXYGENASE 1; HYDROGEN PEROXIDE; MALONALDEHYDE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEME OXYGENASE 1 GENE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; UMBILICAL VEIN ENDOTHELIAL CELL;

AGED; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HEME OXYGENASE-1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; MALE; MALONDIALDEHYDE; MIDDLE AGED; ODDS RATIO; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TANDEM REPEAT SEQUENCES;

EID: 84863585375     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-011-0309-z     Document Type: Article

References (42)

1. Alam J, Den Z (1992) Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267(30):21894-21900
2. Anwar AA, Li FY, Leake DS, Ishii T, Mann GE, Siow RC (2005) Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med 39(2):227-236 (Pubitemid 40814548)
3. Bai CH, Chen JR, Chiu HC, Chou CC, Chau LY, Pan WH (2010) Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. J Biomed Sci 17:12
4. Chen YH, Chau LY, Chen JW, Lin SJ (2008) Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymor-phism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31(8):1615-1620
5. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111(1):1-8
6. Chen YH, Yet SF, Perrella MA (2003) Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 228(5):447-453 (Pubitemid 37203658)
7. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY, Sobel RA, Steinman L, Soares MP (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117(2):438-447. doi:10.1172/JCI28844 (Pubitemid 46203972)
8. Dalton T, Palmiter RD, Andrews GK (1994) Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res 22(23):5016-5023
9. Djousse L, Levy D, Cupples LA, Evans JC, DAgostino RB, Ellison RC (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87 (10):1196-1200,A1194, 1197 (Pubitemid 32453243)
10. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR (2009) Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 42(7-8):666-671
11. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG (2001) Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7(6):693-698. doi:10.1038/89068 (Pubitemid 32588025)
12. Exner M, Minar E, Wagner O, Schillinger M (2004) The roleof heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37(8):1097-1104. doi:10.1016/j.freerad-biomed.2004.07.008
13. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O (2001) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with reste-nosis after percutaneous transluminal angioplasty J Endovasc Ther 8(5):433-440
14. Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19(3):257-267 (Pubitemid 26070354)
15. Idriss NK, Blann AD, Lip GY (2008) Hemoxygenase-1 in cardiovas-cular disease. J Am Coll Cardiol 52(12):971-978
16. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ (1997) Induction of heme oxygenase-1 inhibits the monocyte transmi-gration induced by mildly oxidized LDL. J Clin Invest 100 (5):1209-1216 (Pubitemid 27386307)
17. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, Maruyama Y (2001a) Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104(15):1831-1836 (Pubitemid 32963350)
18. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y Lusis AJ (2001b) Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88 (5):506-512 (Pubitemid 32240914)
19. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22(10):1680-1685
20. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25(1):155-160 (Pubitemid 40054269)
21. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100(1):145-147 (Pubitemid 27309669)
22. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z, Zunic G (2007) Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 40(3-4):181-187 (Pubitemid 46111070)
23. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG (1994) Identification ofbinding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A 91(13):5987-5991 (Pubitemid 24188267)
24. Morita T (2005) Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25(9):1786-1795 (Pubitemid 41243444)
25. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y Strauss WE, Oates JA, Roberts LJ 2nd (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage The New Englandjournal of medicine 332(18):1198-1203
26. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardi-zation of clinical nomenclature (1979). Circulation 59 (3):607-609
27. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (2):351-358 (Pubitemid 9194347)
28. Ponka P (1999) Cell biology ofheme. Am J Med Sci 318(4):241-256
29. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A (1999) Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization Diabetes research and clinical practice 44(1):21-26 (Pubitemid 29446185)
30. Rueda B, Oliver J, Robledo G, Lopez-Nevot MA, Balsa A, Pascual-Salcedo D, Gonzalez-Gay MA, Gonzalez-Escribano MF, Martin J (2007) HO-1 promoter polymorphism associated with rheuma-toid arthritis. Arthritis Rheum 56(12):3953-3958. doi:10.1002/ art.23048 (Pubitemid 350262322)
31. Siow RC, Ishii T, Sato H, Taketani S, Leake DS, Sweiry JH, Pearson JD, Bannai S, Mann GE (1995) Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett 368(2):239-242
32. Song F, Li X, Zhang M, Yao P, Yang N, Sun X, Hu FB, Liu L (2009) Association between heme oxygenase-1 gene promoter poly- morphisms and type 2 diabetes in a Chinese population. Am J Epidemiol 170(6):747-756
33. Sowers JR (2002) Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346(25):1999-2001 (Pubitemid 34651362)
34. Stephens JW, Khanolkar MP, Bain SC (2009) The biological relevance and measurement of plasma markers ofoxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202(2):321-329
35. Stocker R, Perrella MA (2006) Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114(20):2178-2189 (Pubitemid 44747899)
36. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase-1 inatheroscleroticlesions. AmJPathol152(3):711-720
37. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K(2006) Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 114(21):2217-2225 (Pubitemid 44789496)
38. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibil- ity to emphysema. Am J Hum Genet 66(1):187-195 (Pubitemid 30481482)
39. Yamaguchi M, Sato H, Bannai S (1993) Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem Biophys Res Commun 193 (3):1198-1201
40. Yang X, Zheng J, Bai Y, Tian F, Yuan J, Sun J, Liang H, Guo L, Tan H, Chen W, Tanguay RM, Wu T (2007) Using lymphocyte and plasma Hsp70 as biomarkers for assessing coke oven exposure among steel workers. Environ Health Perspect 115(11):1573-1577. doi:10.1289/ehp.10104
41. Zhou L, Zhang X, He M, Cheng L, Chen Y, Hu FB, Wu T (2008) Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 28(11):2085-2089
42. Shi Y Zhou L, Huang LH, Lian YT, Zhang XM, Guo H, Wu TC, Cheng LX, He MA (2011) Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: a case-control study. Atherosclerosis. doi:10.1016/j. atherosclerosis.2011.05.040